# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Epileptic encephalopathy, early infantile, 2

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-9 of 9 results.
Compassionate Use of Stiripentol in Dravet Syndrome
Status: Available
Last Changed: May 10, 2018
First Received: Apr 18, 2013
Disease(s): Dravet Syndrome
Intervention(s): Stiripentol
Locations: Children's Hospital Colorado, Aurora, Colorado, United States
A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Status: Recruiting
Last Changed: Jan 15, 2019
First Received: Jul 11, 2016
Disease(s): Dravet Syndrome
Intervention(s): ZX008 - 0.8 mg/kg/day, ZX008 - 0.2 mg/kg/day, Placebo
Locations: Melbourne Brain Centre Austin Hospital, Melbourne, Australia
Princes Margaret Hospital, Perth, Australia
Children's Health Queensland Hospital and Health Service at Lady Cilento Children's Hospital, South Brisbane, Australia
The Children's Hospital Westmead Dept. of Neurology and Neurosurgery, Westmead, Australia
Universitair Ziekenhuis Antwerpen, Antwerp, Belgium
... and 27 other locations.
Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome
Status: Recruiting
Last Changed: Jan 08, 2019
First Received: Sep 12, 2016
Disease(s): Dravet Syndrome
Intervention(s): measure of neuronal excitability
Locations: Fondation Ophtalmologique Adolphe de Rothschild, Paris, France
Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Status: Available
Last Changed: Jul 30, 2018
First Received: Nov 14, 2013
Disease(s): Dravet Syndrome
Intervention(s): Stiripentol
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
ZX008 Expanded Access Protocol
Status: Available
Last Changed: Dec 19, 2018
First Received: Dec 19, 2018
Disease(s): Dravet Syndrome
Intervention(s): Fenfluramine Hydrochloride
A Phase 2, Prospective, Interventional, Open-Label, Multi-Site, Extension Study to Assess the Long-Term Safety and Tolerability of TAK-935 (OV935) as Adjunctive Therapy in Patients With Rare Epilepsy
Status: Recruiting
Last Changed: Feb 15, 2019
First Received: Aug 17, 2018
Disease(s): Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome, Dup15q Syndrome, CDKL5 Deficiency Disorder
Intervention(s): TAK-935
Locations: 21st Century Neurology, Phoenix, Arizona, United States
Pediatric Neurology PA, Orlando, Florida, United States
Medsol Clinical Research Center Inc, Port Charlotte, Florida, United States
University of South Florida, Tampa, Florida, United States
Rare Disease Research, LLC, Atlanta, Georgia, United States
... and 5 other locations.
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Patients With Developmental and/or Epileptic Encephalopathies
Status: Recruiting
Last Changed: Feb 15, 2019
First Received: Aug 28, 2018
Disease(s): Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome
Intervention(s): TAK-935, Placebo
Locations: Colorado Children's Hospital, Aurora, Colorado, United States
Nicklaus Children's Hospital, Miami, Florida, United States
Pediatric Neurology PA, Orlando, Florida, United States
Rare Disease Research, LLC, Atlanta, Georgia, United States
Center for Rare Neurological Diseases, Norcross, Georgia, United States
... and 7 other locations.
Genetics of Severe Early Onset Epilepsies
Status: Recruiting
Last Changed: Oct 04, 2018
First Received: May 21, 2013
Disease(s): Epilepsy, Epileptic Encephalopathy, Ohtahara Syndrome, Infantile Spasms, Dravet Syndrome, Malignant Migrating Partial Epilepsy of Infancy, Early Myoclonic Epileptic Encephalopathy, PCDH19-related Epilepsy and Related Conditions
Locations: Boston Children's Hospital, Boston, Massachusetts, United States
Cannabidiol in Children With Refractory Epileptic Encephalopathy
Status: Recruiting
Last Changed: Oct 15, 2018
First Received: Jan 19, 2017
Disease(s): Epileptic Encephalopathy
Intervention(s): CanniMed® 1:20
Locations: University of British Columbia, Vancouver, British Columbia, Canada
University of Manitoba, Winnipeg, Manitoba, Canada
Universite de Montreal, Montreal, Quebec, Canada
University of Saskatchewan, Saskatoon, Saskatchewan, Canada